NCT00738959View on ClinicalTrials.gov

Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese

PHASE1CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Healthy Volunteers

Interventions

DRUG

AZD0328

Oral solution A single dose Day 1 followed by once daily doses on Day 3-7

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY